Spots Global Cancer Trial Database for Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
Official Title: Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
Study ID: NCT05648370
Interventions
Study Description
Brief Summary: A prospective, observational study that assesses the clinical feasibility of ctDNA-based liquid biopsy in patients with oligometastatic NSCLC receiving surgery.
Detailed Description: 60 eligible patients will be enrolled. Dynamic blood samples before and after surgery and tissue samples will be obtained for exploratory analysis.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China
Contact Details
Name: Wen-Zhao Zhong, Ph.D
Affiliation: Guangdong Provincial People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
